Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 186

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 186
---
We have entered into
employment agreements with each of our executive officers. Under these agreements, each of our executive officers is employed for an
initial term of 12 months commencing on September 1, 2024 (the “Initial Term”), unless earlier terminated pursuant to the
terms of the employment agreement. Upon the expiration of the Intial Term, the employment shall be automatically extended for successive
periods of 12 months each (each, an “Extension Period”) unless either party shall have given 30 days advance written notice
prior to the end of the relevant Extension Period that the term of the employment agreement is not to be extended. Either party may terminate
the employment agreement by giving 30 days advance written notice to the other party. If an executive officer’s employment is terminated
by us for certain acts of the executive officer, such as a conviction of criminal officer, act of fraud or dishonesty, gross negligence,
willful material misrepresentation, misconduct or a failure to comply with any of the executive officer’s material obligations
(the “Causes”), we shall pay the executive officer his/her salary through the date of termination and we shall have no additional
obligations to the executive officer. If we terminate the executive officer’s position without Causes, we shall continue to pay
the executive all compensation during the notice period.

Each executive officer has agreed to hold
in confidence our confidential information and owe us and third parties a duty to hold the confidential or proprietary information we
received from such parties in strict confidence. In addition, each executive officer has agreed to be bound by non-competition and non-solicitation restrictions
during the term of his or her employment and typically for 12 months following the last date of employment.

We have also entered into indemnification agreements with each of our directors and executive officers. Under these agreements, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director or officer of our company.

<div align='center'>104

COMPENSATION</div>

Compensation of Executive Officers

For the years ended March 31, 2024, we paid an aggregate of nil and $436,830 in cash to the Company’s executive officers and directors, respectively. We have not set aside or accrued any amount to provide pension, retirement or other similar benefits to our directors and executive officers.

Compensation of Directors

For the years ended March 31, 2024, we paid
$426